Patrys Competitors and Similar CompaniesClear all
Patrys's competitors and similar companies include Exelixis.
 Patrys Patrys is a drug development company that commercializes antibody technologies for the treatment of cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South Melbourne, AU HQ | Locations Alameda, US HQ |
Employees | Employees N/A | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 5.4 m | Valuation ($) 8.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $807k (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit $807k (FY, 2025) | Gross profit $2.2b (FY, 2025) |
Net income | Net income ($3m) (FY, 2025) | Net income $782.6m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company